Considering the important role of PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways in ccRCC, we assessed the phosphorylation status of their downstream effectors. This evidence concerns the gene MAPK1 and nonpapillary renal cell carcinoma.